Oncocross (382150) Financial Statements

Income Statement

YearRevenueOp ProfitNet IncomeSource
2025-8.9 billion KRW[source]
20241.1 billion KRW-7.0 billion KRW-6.5 billion KRW[source]
202392 million KRW-6.8 billion KRW-4.2 billion KRW[source]
2022150 million KRW-10.0 billion KRW-10.2 billion KRW
2021100 million KRW-7.3 billion KRW-13.1 billion KRW

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202528.2 billion KRW15.2 billion KRW13.0 billion KRW[source]
202421.8 billion KRW1.7 billion KRW20.1 billion KRW[source]
202316.8 billion KRW651 million KRW16.1 billion KRW[source]
2022
2021

This company has no revenue account in the DART financial statements. Industry-specific accounts such as insurance or interest income are not converted to revenue.

Figures for the relevant year were not collected.

Years without a source link are outside the DART financial API collection period.